Dschang District Hospital
Dschang, Yaoundé, Cameroon
NCT Number: NCT02945111
The purpose of this study is to assess whether the degree of anxiety experienced by women undergoing visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) can be reduced by watching the procedure in real-time on a digital screen.
Looking for future studies?
Notify Me30 year–49 year
Female
Interventional
Not applicable
Dschang, Yaoundé, Cameroon
The study took place in the District of Dschang, Cameroon. Women aged between 30 and 49 years, addressed to undergo a pelvic examination with VIA and VILI, were invited to participate. Throughout the examination, one part of the women underwent the routine VIA/VILI, with no visual support (control group), whereas the other part of patients were shown the pictures of the cervix in real-time on a digital screen (study group). At the end of the procedure, all women had the possibility to see the pictures retrospectively. Randomization determined the women's distribution between the two groups. Their anxiety level was measured by asking them to complete the Spielberg's State Anxiety Inventory (STAI) both prior to and immediately after the procedure.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within thirty minutes of the VIA/VILI examination
Anxiety level will be assessed through the STAI questionnaire
Prof. Patrick Petignat
Other
Watching Live VIA/VILI Examinations on a Digital Screen May Reduce Patients' Anxiety: a Randomized Trial of an Educational Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04630327
Adnexal Diseases, Anxiety
Almaty, Kazakhstan
View Trial DetailsNCT05662683
Anxiety Disorders, Cervical Cancer
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT02096783
Adnexal Diseases, Anxiety Disorder
Madison, Wisconsin, United States
View Trial DetailsNCT02465892
Adnexal Diseases, Anxiety Disorders
Durham, North Carolina, United States
View Trial Details